Skip to main navigation Skip to search Skip to main content

Elucidation of a novel sialic acid metabolism pathway in mucus-foraging bacteria unravels mechanisms of adaptation to the gut

  • Andrew Bell
  • , Jason Brunt
  • , Emmanuelle Crost
  • , Laura Vaux
  • , Ridvan Nepravishta
  • , David Owen
  • , Dimitrios Latousakis
  • , An Xiao
  • , Wanqing Li
  • , Xi Chen
  • , Martin A. Walsh
  • , Jan Claesen
  • , Jesus Angulo
  • , Gavin H. Thomas
  • , Nathalie Juge (Lead Author)

    Research output: Contribution to journal › Article › peer-review

    129 Citations (Scopus)
    31 Downloads (Pure)

    Abstract

    N-acetylneuraminic acid (Neu5Ac), the most abundant sialic acid form in humans, is commonly found in a terminal location on colonic mucins glycans where it is a much-coveted source of nutrients for gut bacteria. The mucin-foraging strategy of the human gut symbiont Ruminococcus gnavus is associated with the expression of an intramolecular trans-sialidase (IT-sialidase) that targets and cleaves off terminal α2–3 -linked Neu5Ac from glycoproteins, releasing 2,7-anhydro-Neu5Ac instead of Neu5Ac. Using a combination of in silico, molecular, biochemical and structural approaches, we have unravelled a unique metabolic pathway leading to the transport and metabolism of 2,7-anhydro-Neu5Ac which is underpinned by the exquisite specificity of the sialic acid transporter. The substrate binding protein, which forms part of a sialic acid transporter (SAT2) in R. gnavus ATCC29149, is specific to 2,7-anhydro-Neu5Ac, as shown by fluorescence spectroscopy, isothermal titration calorimetry (ITC), and saturation transfer difference nuclear magnetic resonance spectroscopy (STD NMR). Once inside the cell, 2,7-anhydro-Neu5Ac is converted into Neu5Ac via a novel enzymatic reaction catalysed by an oxidoreductase, RgNanOx. Following this conversion, Neu5Ac is then catabolised into N-acetylmannosamine (ManNAc) and pyruvate via the action of a Neu5Ac specific aldolase that is structurally and biochemically typical of NanA-like enzymes, as shownby X-ray crystallography of RgNanA wild-type and site-directed active site mutant K167A in complex with Neu5Ac. We confirmed the importance of this metabolic pathway in vivo by generating a R. gnavus nan cluster deletion mutant that lost the ability to grow on sialylated substrates. We showed that in gnotobiotic mice colonised with R. gnavus wild-type and mutant strains, the fitness of the nan mutant was significantly impaired as compared to the wild-type strain with a reduced ability to colonise the mucus layer. Overall, our study revealed a novel sialic acid pathway in bacteria, which has significant implications for the spatial adaptation of mucin-foraging gut symbionts in health and disease.
    Original languageEnglish
    Pages (from-to)2393–2404
    Number of pages12
    JournalNature Microbiology
    Volume4
    Early online date21 Oct 2019
    DOIs
    Publication statusPublished - Dec 2019

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Cite this